Last reviewed · How we verify
NCT03917056
Cap-assisted Endoscopic Sclerotherapy for Internal Hemorrhoids and Rectal Prolapse
NA trial testing Cap-assisted endoscopic sclerotherapy using long needle in Internal Hemorrhoid in 1,000 participants. Currently enrolling.
1 March 2025
Quick facts
| Lead sponsor | The Second Hospital of Nanjing Medical University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 1,000 |
| Start date | 24 June 2019 |
| Primary completion | 1 March 2025 |
| Estimated completion | 27 March 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Cap-assisted endoscopic sclerotherapy using long needle
- Cap-assisted endoscopic sclerotherapy using short needle
Conditions studied
- Internal Hemorrhoid — all drugs for Internal Hemorrhoid →
- Rectal Prolapse — all drugs for Rectal Prolapse →
Sponsor
The Second Hospital of Nanjing Medical University
Who can join
Eligibility, any sex, with Internal Hemorrhoid or Rectal Prolapse. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical trial aims to evaluate the efficacy and safety of long needle and short needle in the treatment of internal hemorrhoids and rectal prolapse through CAES (Cap-assisted endoscopic sclerotherapy).
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Cap-assisted endoscopic sclerotherapy for internal hemorrhoids: technique protocol and study design for a multi-center randomized controlled trial.
Wu X, Wen Q, Cui B, Liu Y, et al · · 2020 · cited 9× · PMID 32551439 · DOI 10.1177/2631774520925636 -
Shifting Paradigms in Hemorrhoid Management: The Emergence and Impact of Cap-Assisted Endoscopic Sclerotherapy.
Wang X, Wu X, Wen Q, Cui B, et al · · 2024 · cited 2× · PMID 39685741 · DOI 10.3390/jcm13237284
Verify or expand the search:
- PubMed search for NCT03917056
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Internal Hemorrhoid
Currently open trials in the same condition.
- NCT04169152 — CAES for Internal Hemorrhoids and Rectal Prolapse · recruiting
Other The Second Hospital of Nanjing Medical University trials
Trials by the same sponsor.
- NCT07331688 — CMTS0515-auWMT for Radiation Enteritis · Phase 1, PHASE2 · active not recruiting
- NCT06839586 — CMTS4520 for Chronic Diarrhoea in Adults · Phase 1, PHASE2 · active not recruiting
- NCT06839599 — CMTS4520-Assisted Washed Microbiota Transplantation for Chronic Diarrhoea in Adults · Phase 1, PHASE2 · not yet recruiting
- NCT06844708 — CMTS0929 for Inflammatory Bowel Disease · EARLY_PHASE1 · not yet recruiting
- NCT06836427 — CMTS0929 for Clostridioides Difficile Infection · EARLY_PHASE1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03917056 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Second Hospital of Nanjing Medical University
- Last refreshed: 2 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03917056.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing